Table 2. Incidence of 30-Day Venous Thromboembolism (VTE) Among Participants (n = 220 588) by Diagnosis Location and SARS-CoV-2 Status.
Location | No. (rate per 1000 participants) | P valuea | |
---|---|---|---|
SARS-CoV-2 positive (n = 26 104) | SARS-CoV-2 negative (n = 194 484) | ||
All VTE eventsb | 198 (7.6) | 1008 (5.2) | <.001 |
Outpatient VTE | 47 (1.8) | 434 (2.2) | .16 |
Hospital-associated VTE | 151 (5.8) | 574 (3.0) | <.001 |
Inpatient | 125 (4.8) | 352 (1.8) | <.001 |
Posthospitalization | 26 (1.0) | 222 (1.1) | .51 |
Viral testing | |||
Outpatient | 117 of 24 746 (4.7) | 297 of 182 074 (1.6) | <.001 |
Inpatient | 81 of 1358 (59.6) | 711 of 12 410 (57.3) | .72 |
Abbreviation: IQR, interquartile range.
χ2 test.
Outpatient, occurring in outpatient or emergency department settings; hospital-associated VTE, occurring during or after hospitalization.